Uhlén, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015).

Article  PubMed  Google Scholar 

Lundstrom, K. An overview on GPCRs and drug discovery: structure-based drug design and structural biology on GPCRs. Methods Mol. Biol. 552, 51–66 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carter, P. J. & Rajpal, A. Designing antibodies as therapeutics. Cell 185, 2789–2805 (2022).

Article  CAS  PubMed  Google Scholar 

Urquhart, L. Top companies and drugs by sales in 2022. Nat. Rev. Drug. Discov. 22, 260 (2023).

Article  CAS  PubMed  Google Scholar 

Carter, P. J. & Lazar, G. A. Next generation antibody drugs: pursuit of the ‘high-hanging fruit’. Nat. Rev. Drug. Discov. 17, 197–223 (2018).

Article  CAS  PubMed  Google Scholar 

Laustsen, A. H., Greiff, V., Karatt-Vellatt, A., Muyldermans, S. & Jenkins, T. P. Animal immunization, in vitro display technologies, and machine learning for antibody discovery. Trends Biotechnol. 39, 1263–1273 (2021).

Article  CAS  PubMed  Google Scholar 

Kunert, R. & Reinhart, D. Advances in recombinant antibody manufacturing. Appl. Microbiol. Biotechnol. 100, 3451–3461 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mullard, A. FDA approves 100th monoclonal antibody product. Nat. Rev. Drug. Discov. 20, 491–495 (2021).

Article  CAS  PubMed  Google Scholar 

Sakamoto, K. M. et al. Protacs: chimeric molecules that target proteins to the Skp1–Cullin–F box complex for ubiquitination and degradation. Proc. Natl Acad. Sci. USA 98, 8554–8559 (2001).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schreiber, S. L. The rise of molecular glues. Cell 184, 3–9 (2021).

Article  CAS  PubMed  Google Scholar 

Békés, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. 21, 181–200 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Rousseau, A. & Bertolotti, A. Regulation of proteasome assembly and activity in health and disease. Nat. Rev. Mol. Cell Biol. 19, 697–712 (2018).

Article  CAS  PubMed  Google Scholar 

Oh, E., Akopian, D. & Rape, M. Principles of ubiquitin-dependent signaling. Annu. Rev. Cell Dev. Biol. 34, 137–162 (2018).

Article  CAS  PubMed  Google Scholar 

Duan, S. & Pagano, M. Ubiquitin ligases in cancer: functions and clinical potentials. Cell Chem. Biol. 28, 918–933 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dikic, I. & Schulman, B. A. An expanded lexicon for the ubiquitin code. Nat. Rev. Mol. Cell Biol. 24, 273–287 (2023).

Article  CAS  PubMed  Google Scholar 

Zhang, Z. et al. Role of lysosomes in physiological activities, diseases, and therapy. J. Hematol. Oncol. 14, 79 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Riching, K. M. et al. Quantitative live-cell kinetic degradation and mechanistic profiling of PROTAC mode of action. ACS Chem. Biol. 13, 2758–2770 (2018).

Article  CAS  PubMed  Google Scholar 

Kannt, A. & Đikić, I. Expanding the arsenal of E3 ubiquitin ligases for proximity-induced protein degradation. Cell Chem. Biol. 28, 1014–1031 (2021).

Article  CAS  PubMed  Google Scholar 

Jevtić, P., Haakonsen, D. L. & Rapé, M. An E3 ligase guide to the galaxy of small-molecule-induced protein degradation. Cell Chem. Biol. 28, 1000–1013 (2021).

Article  PubMed  Google Scholar 

Poirson, J. et al. Proteome-scale induced proximity screens reveal highly potent protein degraders and stabilizers. bioRxiv 2022.08.15.503206 Preprint at https://doi.org/10.1101/2022.08.15.503206 (2022).

Zhao, L., Zhao, J., Zhong, K., Tong, A. & Jia, D. Targeted protein degradation: mechanisms, strategies and application. Signal Transduct. Target. Ther. 7, 113 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin, J. et al. Emerging protein degradation strategies: expanding the scope to extracellular and membrane proteins. Theranostics 11, 8337–8349 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pei, J. et al. Targeting lysosomal degradation pathways: new strategies and techniques for drug discovery. J. Med. Chem. 64, 3493–3507 (2021).

Article  CAS  PubMed  Google Scholar 

Dumontet, C., Reichert, J. M., Senter, P. D., Lambert, J. M. & Beck, A. Antibody–drug conjugates come of age in oncology. Nat. Rev. Drug. Discov. 22, 641–661 (2023).

Article  CAS  PubMed  Google Scholar 

Sterner, R. C. & Sterner, R. M. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 11, 69 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Goebeler, M.-E. & Bargou, R. C. T cell-engaging therapies — BiTEs and beyond. Nat. Rev. Clin. Oncol. 17, 418–434 (2020).

Article  PubMed  Google Scholar 

Crews, C. M. Targeting the undruggable proteome: the small molecules of my dreams. Chem. Biol. 17, 551–555 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jayson, G. C. et al. Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer. Eur. J. Cancer 41, 555–563 (2005).

Article  CAS  PubMed  Google Scholar 

Xiao, J. J. et al. Pharmacokinetics of anti-hepcidin monoclonal antibody Ab 12B9m and hepcidin in cynomolgus monkeys. AAPS J. 12, 646–657 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Byrd, J. C. et al. Phase 1 study of lumiliximab with detailed pharmacokinetic and pharmacodynamic measurements in patients with relapsed or refractory chronic lymphocytic leukemia. Clin. Cancer Res. 13, 4448–4455 (2007).

Article  CAS  PubMed  Google Scholar 

Clark, R. G. et al. Recombinant human growth hormone (GH)-binding protein enhances the growth-promoting activity of human GH in the rat. Endocrinology 137, 4308–4315 (1996).

Article  CAS  PubMed  Google Scholar 

Pyzik, M., Kozicky, L. K., Gandhi, A. K. & Blumberg, R. S. The therapeutic age of the neonatal Fc receptor. Nat. Rev. Immunol. 23, 415–432 (2023).

Article  CAS  PubMed  Google Scholar 

Latvala, S., Jacobsen, B., Otteneder, M. B., Herrmann, A. & Kronenberg, S. Distribution of FcRn across species and tissues. J. Histochem. Cytochem. 65, 321–333 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuo, T. T. et al. Neonatal Fc receptor: from immunity to therapeutics. J. Clin. Immunol. 30, 777–789 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Igawa, T., Haraya, K. & Hattori, K. Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation. Immunol. Rev. 270, 132–151 (2016).

Article  CAS  PubMed  Google Scholar 

Rudenko, G. et al. Structure of the LDL receptor extracellular domain at endosomal pH. Science 298, 2353–2358 (2002).

Article  CAS  PubMed  Google Scholar 

Mircic, M. & Kavanaugh, A. The clinical efficacy of tocilizumab in rheumatoid arthritis. Drugs Today 45, 189 (2009).

Article  Google Scholar 

Rose-John, S., Scheller, J., Elson, G. & Jones, S. A. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J. Leukoc. Biol. 80, 227–236 (2006).

Article  CAS  PubMed  Google Scholar